Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
Clinical trial NCT00434733 · COMPLETED
Trial details
- NCT number
- NCT00434733
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Enrollment
- 4400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.